Home › Sjögren's Disease › Illinois › Cicero
Sjögren's Disease clinical trials in Cicero, IL
4 studies for Sjögren's Disease are looking for participants at sites in and around Cicero (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
RecruitingPhase 2
- Willow Rheumatology Wellness, Willowbrook · 11 mi away
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
RecruitingPhase 3
- Willow Rheumatology Wellness, Willowbrook · 11 mi away
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
RecruitingPhase 3
- Willow Rheumatology & Wellness, Willowbrook · 11 mi away
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Willowbrook, Willowbrook · 11 mi away
About Sjögren's Disease
Sjögren's disease is an autoimmune disease that causes dryness of the mouth, eyes, and other parts of the body. Learn how to relieve the symptoms.
More about Sjögren's Disease on MedlinePlus
Sjögren's Disease trials in other cities
- Washington, DC6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Tampa, FL4 studies
- Clearwater, FL4 studies
- Arlington, TX4 studies
- Charlotte, NC4 studies
- Oklahoma City, OK3 studies
- Memphis, TN3 studies
- Philadelphia, PA3 studies
- Chicago, IL3 studies
- Orlando, FL3 studies
Other studies in Cicero
- Non-Small Cell Lung Cancer23 studies
- Lung Cancer18 studies
- Prostate Cancer15 studies
- Cancer (all types)12 studies
- Acute Myeloid Leukemia11 studies
- Breast Cancer10 studies
- Colorectal Cancer9 studies
- Bladder Cancer8 studies
- Melanoma7 studies
- Cardiovascular Disease7 studies
- Pancreatic Cancer6 studies
- Type 2 Diabetes6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.